Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 7(7): e41537, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22844493

RESUMO

To date, genome-wide association studies (GWAS) have identified at least 32 novel loci for obesity and body mass-related traits. However, the causal genetic variant and molecular mechanisms of specific susceptibility genes in relation to obesity are yet to be fully confirmed and characterised. Here, we examined whether the candidate gene NEGR1 encoding the neuronal growth regulator 1, also termed neurotractin or Kilon, accounts for the obesity association. To characterise the function of NEGR1 for body weight control in vivo, we generated two novel mutant mouse lines, including a constitutive NEGR1-deficient mouse line as well as an ENU-mutagenised line carrying a loss-of-function mutation (Negr1-I87N) and performed metabolic phenotypic analyses. Ablation of NEGR1 results in a small but steady reduction of body mass in both mutant lines, accompanied with a small reduction in body length in the Negr1-I87N mutants. Magnetic resonance scanning reveals that the reduction of body mass in Negr1-I87N mice is due to a reduced proportion of lean mass. Negr1-I87N mutants display reduced food intake and physical activity while normalised energy expenditure remains unchanged. Expression analyses confirmed the brain-specific distribution of NEGR1 including strong expression in the hypothalamus. In vitro assays show that NEGR1 promotes cell-cell adhesion and neurite growth of hypothalamic neurons. Our results indicate a role of NEGR1 in the control of body weight and food intake. This study provides evidence that supports the link of the GWAS candidate gene NEGR1 with body weight control.


Assuntos
Peso Corporal/genética , Inativação Gênica , Estudo de Associação Genômica Ampla , Proteínas de Membrana/deficiência , Proteínas de Membrana/genética , Proteínas do Tecido Nervoso/deficiência , Proteínas do Tecido Nervoso/genética , Obesidade/genética , Alelos , Animais , Estatura/genética , Adesão Celular , Linhagem Celular , Dieta Hiperlipídica/efeitos adversos , Ingestão de Alimentos/genética , Retículo Endoplasmático/metabolismo , Metabolismo Energético/genética , Feminino , Técnicas de Inativação de Genes , Genótipo , Humanos , Hipotálamo/citologia , Hipotálamo/metabolismo , Masculino , Proteínas de Membrana/metabolismo , Camundongos , Atividade Motora/genética , Proteínas do Tecido Nervoso/metabolismo , Neuritos/metabolismo , Obesidade/metabolismo , Obesidade/patologia , Obesidade/fisiopatologia , Fenótipo
2.
Expert Rev Mol Med ; 13: e1, 2011 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-21211090

RESUMO

The use of mouse models in medical research has greatly contributed to our understanding of the development of type 2 diabetes mellitus and the mechanisms of disease progression in the context of insulin resistance and ß-cell dysfunction. Maintenance of glucose homeostasis involves a complex interplay of many genes and their actions in response to exogenous stimuli. In recent years, the availability of large population-based cohorts and the capacity to genotype enormous numbers of common genetic variants have driven various large-scale genome-wide association studies, which has greatly accelerated the identification of novel genes likely to be involved in the development of type 2 diabetes. The increasing demand for verifying novel genes is met by the timely development of new mouse resources established as various collaborative projects involving major transgenic and phenotyping centres and laboratories worldwide. The surge of new data will ultimately enable translational research into potential improvement and refinement of current type 2 diabetes therapy options, and hopefully restore quality of life for patients.


Assuntos
Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/fisiopatologia , Modelos Animais de Doenças , Camundongos , Animais , Estudos de Coortes , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/terapia , Estudo de Associação Genômica Ampla , Glucose/metabolismo , Humanos , Insulina/fisiologia , Resistência à Insulina/genética , Células Secretoras de Insulina/fisiologia , Locos de Características Quantitativas , Transdução de Sinais , Pesquisa Translacional Biomédica
3.
PLoS Genet ; 5(11): e1000748, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19956733

RESUMO

Palmitoylation is a key post-translational modification mediated by a family of DHHC-containing palmitoyl acyl-transferases (PATs). Unlike other lipid modifications, palmitoylation is reversible and thus often regulates dynamic protein interactions. We find that the mouse hair loss mutant, depilated, (dep) is due to a single amino acid deletion in the PAT, Zdhhc21, resulting in protein mislocalization and loss of palmitoylation activity. We examined expression of Zdhhc21 protein in skin and find it restricted to specific hair lineages. Loss of Zdhhc21 function results in delayed hair shaft differentiation, at the site of expression of the gene, but also leads to hyperplasia of the interfollicular epidermis (IFE) and sebaceous glands, distant from the expression site. The specific delay in follicle differentiation is associated with attenuated anagen propagation and is reflected by decreased levels of Lef1, nuclear beta-catenin, and Foxn1 in hair shaft progenitors. In the thickened basal compartment of mutant IFE, phospho-ERK and cell proliferation are increased, suggesting increased signaling through EGFR or integrin-related receptors, with a parallel reduction in expression of the key differentiation factor Gata3. We show that the Src-family kinase, Fyn, involved in keratinocyte differentiation, is a direct palmitoylation target of Zdhhc21 and is mislocalized in mutant follicles. This study is the first to demonstrate a key role for palmitoylation in regulating developmental signals in mammalian tissue homeostasis.


Assuntos
Aciltransferases/genética , Diferenciação Celular , Células Epidérmicas , Folículo Piloso/citologia , Homeostase , Lipoilação/fisiologia , Animais , Mutação da Fase de Leitura , Camundongos , Processamento de Proteína Pós-Traducional , Proteínas Proto-Oncogênicas c-fyn/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...